SCHOTT Pharma AG
Sector and Industry
Healthcare, Healthcare Services
Performance (1Y)
39.33%
Market Cap
2.58 Bil.
P/E Ratio
21.70
Dividend Yield
0.85 %
Earnings per Share
0.97 €
Peer Group
| Company Name | Market Cap | Revenue Last Reported Year | P/E Ratio | Profit Growth 1Y | Last Price | Previous Trading Day Change |
|---|---|---|---|---|---|---|
| UnitedHealth Group Inc. | 254.66 Bil. | 396.73 Bil. | 24.94 | -19.75 % | 0.00 | - |
| Thermo Fisher Scientific Inc. | 185.62 Bil. | 39.50 Bil. | 32.67 | +1.45 % | 0.00 | - |
| Danaher Corp. | 137.79 Bil. | 21.78 Bil. | 45.36 | -11.47 % | 0.00 | - |
| McKesson Corporation | 90.13 Bil. | 348.09 Bil. | 22.55 | +33.83 % | 0.00 | - |
| HCA Healthcare Inc. | 89.28 Bil. | 67.01 Bil. | 16.48 | +12.93 % | 0.00 | - |
| Elevance Health Inc. | 65.88 Bil. | 176.51 Bil. | 13.91 | -9.22 % | 0.00 | - |
| The Cigna Group | 61.74 Bil. | 243.65 Bil. | 12.41 | +66.33 % | 0.00 | - |
| Cencora Inc. | 51.58 Bil. | 291.15 Bil. | 39.26 | +1.16 % | 0.00 | - |
| IDEXX Laboratories Inc. | 45.92 Bil. | 3.81 Bil. | 51.74 | +14.41 % | 0.00 | - |
| Zoetis Inc. | 45.52 Bil. | 8.39 Bil. | 20.89 | +3.10 % | 0.00 | - |
Facts & figures
Price data
| TRADE PLATFORM | Börse Stuttgart (XSTU) | |
| LAST PRICE | 17.14 G | 0 Units |
| PRICE DETERMINATION TIME | 06/03/2026 / 09:55:39 PM | |
| DAILY VOLUME (UNITS) | 810 | |
| DAILY HIGH / LOW | 17.4 | 17.14 |
| PREV. DAY'S PRICE | 17.2 | (06/02) |
| CHANGE DAY BEFORE | -0.06 | -0.35 % |
| 52 WEEK HIGH / LOW | 30.15 (06/12) | 12.62 (03/20) |
Key Figures (in EUR)
| 2027e | 2026e | 2025 | 2024 | 2023 | |
|---|---|---|---|---|---|
| EARNINGS PER SHARE | 1.06 | 0.94 | 0.97 | 0.99 | 1.01 |
| DIVIDENDS PER SHARE | 0.20 | 0.18 | 0.18 | 0.16 | 0.15 |
| DIVIDEND YIELD IN % | - | - | 0.85 % | 0.52 % | 0.47 % |
| DIVIDEND GROWTH IN % | - | - | 12.50 % | 6.67 % | - |
| PRICE - EARNINGS RATIO | 17.24 | 19.45 | 21.70 | 30.85 | 31.38 |
| PRICE - BOOK RATIO | - | - | 3.56 | 5.84 | 6.90 |
| PRICE - SALES RATIO | - | - | 3.22 | 4.82 | 5.30 |
| PRICE - CASH FLOW RATIO | - | - | 17.66 | 20.49 | 26.23 |
Master Data
| WKN | A3ENQ5 |
| ISIN | DE000A3ENQ51 |
| SYMBOL | 1SXP |
| EXCHANGE SEGMENT | Freiverkehr |
| TYPE OF FINANCIAL INSTRUMENT | Equity |
| DENOMINATION | SCHOTT PHARMA INH O.N. |
| INDEX MEMBERSHIP | SDAX |
| TRADING SEGMENT | - |
| TRADING HOURS | 07:30:00 AM - 10:00:00 PM |
| TRADING CURRENCY | Euro |
| NOMINAL CURRENCY | Euro |
| SETTLEMENT CURRENCY | Euro |
| SECTOR AND INDUSTRY | Healthcare, Healthcare Services |
| NUMBER OF SHARES | 150.61 Mil. |
| MARKET CAPITALISATION | 2.58 Bil. |
Performance overview
| 1W | 1M | 3M | 6M | 1Y | 3Y | 5Y | YTD | |
|---|---|---|---|---|---|---|---|---|
| PERFORMANCE | 1.42 % | 16.06 % | 18.13 % | -7.63 % | -39.33 % | - | - | 14.06 % |
| HIGH | 18.22 | 18.22 | 18.22 | 18.96 | 30.15 | - | - | 18.22 |
| LOW | 16.96 | 14.62 | 12.62 | 12.62 | 12.62 | - | - | 12.62 |
Dividend
per share
Company profile
SCHOTT Pharma AG & Co. KgaA engages in the provision of designing drug containment and drug delivery solutions. It operates through the Drug Containment Solutions and Drug Delivery Systems segments. The Drug Containment Solutions segment focuses on the products from the Core category that currently make up the largest part of the DCS product portfolio. The Drug Delivery Systems segment includes products that are characterized by improved product functionality and belong to the HVS product portfolio. It offers a wide range of advanced drug containment solutions and delivery systems for inject able drugs that supply to the pharmaceutical and biotechnology industries. The company was founded on May 10, 2022 and is headquartered in Mainz, Germany.
Structured products for SCHOTT Pharma AG
Analyst Rating
Ø-Target Price DistanceNot Available
Current Price
Not AvailableØ-Target Price
Not AvailableAverage ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0
Company Events
(in 7 days)
06/10/26Citi European Healthcare Leaders Conference
(in 70 days)
08/12/26Q3 2026 Earnings Release
(in 111 days)
09/22/26Bank of America Global Healthcare Conference
(in 112 days)
09/23/26Berenberg and Goldman Sachs German Corporate Conference
(in 113 days)
09/24/26Baader Investment Conference